Brian Lawler

Brian Lawler


Recent articles

Less Is More for Vertex

The company's potential hepatitis C compound proves effective with fewer dosages.

Busy Day for MannKind

It unveils a brand name, a partnership, and new data for its lead drug.

Pfizer Puts Safety First

Increased FDA scrutiny may motivate the pharmaceutical's new drug-safety site.